Applera Corporation, Beth Israel Deaconess Medical Center, Cornell Research Foundation, The Regents of the University of Michigan, Proligo of Boulder, Colo. | GenomeWeb

Applera Corporation of Norwalk, Conn., has received US Patent No. 6,900,040, "Isolated human dehydrogenaseproteins, nucleic acid molecules encoding these human dehydrogenase proteins, and uses thereof." The patented described a DNA microarray that can be used to develop gene expression profiles based on the amino acid sequences of human dehydrogenase polypeptides and proteins. These peptides and proteins are related to the retinol dehydrogenase subfamily, as well as allelic variants and other mammalian orthologs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.